Computer Aided Drug Discovery Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increased Incidences Of Chronic And Undiagnosed Diseases
   3. Market Restraints
      1. High Initial Investment and Operational Costs
      2. Complex Regulatory and Validation Challenges
   4. Market Opportunity
      1. Advancement in the Field Of Computer-Aided Drug Discovery
   5. Market Trends
      1. Integration of Artificial Intelligence (AI) and Machine Learning (ML) in Drug Discovery
      2. Shift Toward Cloud-Based Drug Discovery Platforms
5. MARKET SEGMENTATION
   1. By Type
      1. Structure-based Drug Design
      2. Ligand-based Drug Design
      3. Sequence-based Approaches
   2. By Therapeutic Area
      1. Oncology
      2. Neurology
      3. Cardiovascular diseases
      4. Respiratory diseases
      5. Diabetes
   3. By End User
      1. Pharmaceuticals companies
      2. Biotechnology companies
      3. Research Laboratories
   4. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. AstraZeneca
      2. Albany Molecular Research Inc. (AMRI)
      3. Aris Pharmaceuticals
      4. Aragen Life Sciences Pvt. Ltd.
      5. BOCSCI Inc.
      6. Bioduro-Sundia
      7. Bayer AG
      8. Charles River Laboratories
      9. Schrodinger, Inc.
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global Computer Aided Drug Discovery market?

The global market of Computer Aided Drug Discovery is projected to reach USD10.7Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Computer Aided Drug Discovery market?

The global Computer Aided Drug Discovery market has an estimated annual growth rate of 11.6%.

Q.3. What are the recent trends of Computer Aided Drug Discovery market?

Integration of Artificial Intelligence (AI) and Machine Learning (ML) in drug discovery and shift toward cloud-based drug discovery platformsare some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in Computer Aided Drug Discovery?

The major companies profiled in this report include AstraZeneca, Albany Molecular Research Inc. (AMRI), Aris Pharmaceuticals, Aragen Life Sciences Pvt. Ltd., BOCSCI Inc., Bioduro-Sundia, Bayer AG, Charles River Laboratories, Schrodinger, Inc., among others.   

Q.5. Which is the largest regional market in the Computer Aided Drug Discovery?

North America is the largest regional market for Computer Aided Drug Discovery.